For the fiscal year ending December 2025, an impairment loss of 176 million JPY on investment securities and 303 million JPY on affiliated company shares were recorded as extraordinary losses.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4375","jir_company_name":"Safie, Inc.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-02-13","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/02\/4375-20260213-03.pdf","jir_short_summary":"For the fiscal year ending December 2025, an impairment loss of 176 million JPY on investment securities and 303 million JPY on affiliated company shares were recorded as extraordinary losses.","jir_summary":"### Details of the Recorded Extraordinary Loss\nDuring the full fiscal year ending December 2025, impairment processing was conducted on investment securities held by our consolidated subsidiaries whose fair value declined significantly, resulting in the recording of an \"Impairment Loss on Investment Securities\" of 176 million JPY as an extraordinary loss. Additionally, impairment processing was performed on shares of one consolidated subsidiary and one affiliated company after examining future recoverability, which led to recording an \"Impairment Loss on Affiliated Company Shares\" of 303 million JPY. The impairment loss on affiliated company shares is recorded as a 19 million JPY equity-method investment loss.\n\n### Impact on Performance\nThese extraordinary losses are already reflected in the consolidated financial summary [Japanese GAAP] for the fiscal year ending December 2025 and have negatively impacted the results for that period. Although specific figures for sales and profits are not provided in this document, it is presumed that the recording of extraordinary losses has affected net income and other metrics.","jir_financial_highlights":"Impairment Loss on Investment Securities: 176 million JPY (Unknown)\nImpairment Loss on Affiliated Company Shares: 303 million JPY (Unknown)\nEquity-Method Investment Loss: 19 million JPY (Unknown)","jir_category":"","jir_hashtags":"#SafieInc, #financial_summary, #extraordinary_loss","jir_key_figures":"Impairment Loss on Investment Securities: 176 million JPY (Extraordinary loss due to impairment processing)\nImpairment Loss on Affiliated Company Shares: 303 million JPY (Impairment of shares of consolidated subsidiaries and affiliated companies)\nEquity-Method Investment Loss: 19 million JPY (Impairment loss on affiliated company shares)","jir_meta_title":"Safie, Inc. Records 479 Million JPY Extraordinary Loss for Fiscal Year Ending December 2025","jir_meta_description":"Safie, Inc. recorded an impairment loss of 176 million JPY on investment securities and 303 million JPY on affiliated company shares as extraordinary losses in the fiscal year ending December 2025, impacting financial results.","jir_og_title":"Safie, Inc. Announces Recording of Extraordinary Loss for Fiscal Year Ending December 2025","jir_og_description":"Recorded impairment losses of 176 million JPY on investment securities and 303 million JPY on affiliated company shares for the fiscal year ending December 2025. Important notice including impact on performance.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":17432,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-28751","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n